Patent ID: 6962933

Claim:
A method for treatment of cerebral hemorrhage, cerebral infarction, head trauma, spinal cord injury, brain edema, multiple sclerosis, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, diabetes, osteoporosis, Creutzfeldt-Jakob disease or virus infection, comprising administering an effective amount of a 1,3-thiazole compound to a mammal, wherein the 1,3-thiazole compound is a compound of the formula wherein R 1 represents a hydrocarbon group optionally having substituent(s) selected from the group consisting C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alknyl, C 3-6 cycloalkyl, and C 6-14 aryl; R 2 represents a pyridyl group optionally having substituent(s); and R 3 represents a C 6-14 monocyclic or fused polycyclic aromatic hydrocarbon group optionally having substituent(s), or a salt thereof.